Keeping up to date

A review of the recent changes to prescription medicine listings and new product listings Our monthly review of medicine listing changes, from MIMS Australia New Products Budesonide (Jorveza) is a non-halogenated glucocorticosteroid, which acts primarily as an anti-inflammatory by binding to the glucocorticoid receptor. In the treatment of eosinophilic oesophagitis (EoE), budesonide may inhibit antigen-stimulated

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Losing the trace
Next World news wrapup: 1 April 2021